Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)

Clinical trial NCT01698905 · COMPLETED

Trial details

NCT number: NCT01698905
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2012-12-20
Primary completion: 2015-11-26
Enrollment: 163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.